ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA

This adverse event was reported 34 times

These drugs are most commonly taken by patients reporting ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA:

# Drug Count
0 INFLIXIMAB 12
1 VEDOLIZUMAB 12
2 ADALIMUMAB 11
3 ADALIMUMAB-AATY 11
4 ADALIMUMAB-ADAZ 11
5 ADALIMUMAB-FKJP 11
6 AZATHIOPRINE 11
7 GOLIMUMAB 11
8 MESALAMINE 11
9 RITUXIMAB 11
See all common drugs associated with ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA

ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PURIXAN 1 0.0013
1 FLUTAMIDE 1 0.0010
2 GOLIMUMAB 11 0.0009
3 TOFACITINIB CITRATE 11 0.0008
4 CLOMIPHENE CITRATE 1 0.0007
5 MERCAPTOPURINE 10 0.0006
6 MESALAMINE 11 0.0004
7 ADALIMUMAB-FKJP 11 0.0002
8 ADALIMUMAB-AATY 11 0.0002
9 ADALIMUMAB-ADAZ 11 0.0002
See all drugs enriched for association with ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA